Meeting Report From the 2023 Cure Ocular Melanoma (<scp>CURE OM</scp>) Global Science Meeting, Philadelphia, <scp>PA</scp>, November 2023
The 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting was held in Philadelphia on November 6, 2023. There is increased awareness and dedicated research in uveal melanoma (UM), but unmet needs remain in the prevention, detection, and treatment of UM. The purpose of this meeting was to provide an international forum for the exchange of research ideas, to allow for discussion of basic science as well as clinical research on UM, and to gather input about advocacy and patient needs.
Authors
- Meredith McKean (ORCID: https://orcid.org/0000-0003-0944-7418)
- Michael D. Onken (ORCID: https://orcid.org/0000-0003-4082-1105)
- Kamaneh Montazeri
- Omid Hamid (ORCID: https://orcid.org/0000-0002-8238-4655)
- Marlana Orloff (ORCID: https://orcid.org/0000-0001-9460-2587)
- Rino S. Seedor (ORCID: https://orcid.org/0000-0002-8494-3289)
- Jose Lutzky (ORCID: https://orcid.org/0000-0002-9503-2130)
- Corine Bertolotto (ORCID: https://orcid.org/0000-0001-6971-7753)
- Keiran S.M. Smalley (ORCID: https://orcid.org/0000-0003-1089-9307)
- Andrew E. Aplin (ORCID: https://orcid.org/0000-0002-2734-3244)
- Joseph J. Sacco (ORCID: https://orcid.org/0000-0003-2591-9796)
- Justin C. Moser (ORCID: https://orcid.org/0000-0002-0643-6759)
- Richard D. Carvajal (ORCID: https://orcid.org/0000-0002-3796-1118)
- Rizwan Haq (ORCID: https://orcid.org/0000-0002-1290-9276)
- Shaheer Khan (ORCID: https://orcid.org/0000-0003-3963-0280)
- Sara Selig (ORCID: https://orcid.org/0000-0003-2728-5862)
- Jacqueline Kraska
- Nigel Deacon
- Katie Doble
- Miriam Kadosh
Institutions
- Northwell Health (US)
- University of Miami (US)
- Thomas Jefferson University (US)
- Inserm (FR)
- Washington University in St. Louis (US)
- Clatterbridge Cancer Centre NHS Foundation Trust (GB)
- Moffitt Cancer Center (US)
- Massachusetts General Hospital (US)
- Melanoma Research Foundation (US)
- Sarah Cannon (US)
- Angeles Clinic and Research Institute (US)
- Sidney Kimmel Cancer Center (US)
- Dana-Farber Cancer Institute (US)
- HonorHealth (US)
- Canadian Patient Safety Institute (CA)
- Sylvester Comprehensive Cancer Center (US)
- Patient Advocate Foundation (US)
Publication Details
- Journal
- Pigment Cell & Melanoma Research
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1111/pcmr.13205
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Melanoma Research Foundation
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Melanoma Research Alliance
- Gilead Sciences
- American Society of Clinical Oncology
- Regeneron Pharmaceuticals
- Exelixis
- Celldex Therapeutics
- Novocure
- Tizona Therapeutics
- Foghorn Therapeutics
- BeiGene
- Incyte
- NGM Biopharmaceuticals
- Moderna
- Ascentage Pharma
- G1 Therapeutics
- Castle Biosciences
- Eisai
- Astellas Pharma
- Plexxikon
- Mereo BioPharma
- Genentech
- EMD Serono
- Daiichi Sankyo Europe